<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="44856">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02522351</url>
  </required_header>
  <id_info>
    <org_study_id>13.21. NRC</org_study_id>
    <nct_id>NCT02522351</nct_id>
  </id_info>
  <brief_title>Reduction of Aspiration Through Cohesive Thin Liquids (CTL) in Patients With Mild Oropharyngeal Dysphagia</brief_title>
  <official_title>Reduction of Aspiration Through Cohesive Thin Liquids (CTL) in Patients With Mild Oropharyngeal Dysphagia Due to Ischemic/Hemorrhagic Cerebral Cause (Stroke)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the trial is to identify any systematic effect of cohesiveness on the efficacy of
      swallowing in patients having dysphagia problems.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial will be a double blind, randomized, crossover, controlled, and interventional
      trial. Each subject will test 6 study samples in a randomized order at 5 mL of volume first
      then at 10 mL (12 samples maximum). The trial will last a maximum of one hour (a single
      study visit).

      The total sample size is 47 enrolled subjects, 33 subjects completed. Patients will be
      females and males aged between 18 and 85 years with mild proven dysphagia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">May 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Identification of any systematic effect of cohesiveness on the efficacy of swallowing in dysphagic patients according to Rosenbek's Penetration-Aspiration Score (PAS) using videofluoroscopy</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>The PAS score across each bolus (5 mL and 10 mL)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Swallowing safety- prevalence of penetration</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>The prevalence of penetration in the population according to Rosenbek's PAS (score of 2-5) assessed using videofluoroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing safety- prevalence of aspiration</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>The prevalence of aspiration in the population according to Rosenbek's PAS (score of 6-8) assessed using videofluoroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function- Amount/volume of oral and pharyngeal residues</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>The amount/volume of oral and pharyngeal residues assessed using videofluoroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function- Prevalence of subjects with oral and pharyngeal residues</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>The prevalence of subjects of oral and pharyngeal residues assessed using videofluoroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function- Oral transit time (OTT, time between tongue tip elevation and arrival of the bolus at the ramus of the mandible)</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>Oral transit time (OTT, time between tongue tip elevation and arrival of the bolus at the ramus of the mandible)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function- Swallow response time (SRT, time between arrival of the bolus at the ramus of the mandible and pharyngeal phases of swallowing)</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>Swallow response time (SRT, time between arrival of the bolus at the ramus of the mandible and pharyngeal phases of swallowing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function- Pharyngeal transit time (PTT, time between arrival of the bolus at the ramus of the mandible and the tail of the bolus passing through the upper esophageal sphincter)</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>Pharyngeal transit time (PTT, time between arrival of the bolus at the ramus of the mandible and the tail of the bolus passing through the upper esophageal sphincter)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function- Time to upper esophageal sphincter opening (UESO, time between tongue tip elevation and opening of the upper esophageal sphincter)</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>Time to upper esophageal sphincter opening (UESO, time between tongue tip elevation and opening of the upper esophageal sphincter)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function-Time to laryngeal vestibule opening (LVO, time between tongue tip elevation and pharyngeal phases of swallowing)</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>Time to laryngeal vestibule opening (LVO, time between tongue tip elevation and pharyngeal phases of swallowing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing function- Time to laryngeal vestibule closure (LVC, time between tongue tip elevation and maximal laryngeal closure)</measure>
    <time_frame>During the ingestion (videofluoroscopy), maximum during one hour.</time_frame>
    <description>Time to laryngeal vestibule closure (LVC, time between tongue tip elevation and maximal laryngeal closure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective perception of ease of swallowing and oropharyngeal sensation.</measure>
    <time_frame>Right after ingredient ingestion, maximum during one hour.</time_frame>
    <description>This will be assessed from a questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Anticipated">47</enrollment>
  <condition>Dysphagia</condition>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Thicken Up Clear concentration 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thicken Up Clear at concentration 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thicken Up Clear concentration 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thicken Up Clear at concentration 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thicken Up Clear concentration 3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Thicken Up Clear at concentration 3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cereal extract concentration 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cereal extract at concentration 1</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cereal extract concentration 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cereal extract at concentration 2</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cereal extract concentration 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cereal extract at concentration 3</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cereal extract concentration 1</intervention_name>
    <description>Cereal extract will be given to see the effect on penetration and aspiration in patients with dysphagia problem</description>
    <arm_group_label>Thicken Up Clear concentration 1</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 2</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 3</arm_group_label>
    <arm_group_label>Cereal extract concentration 2</arm_group_label>
    <arm_group_label>Cereal extract concentration 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cereal extract concentration 2</intervention_name>
    <description>Cereal extract will be given to see the effect on penetration and aspiration in patients with dysphagia problem</description>
    <arm_group_label>Thicken Up Clear concentration 1</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 2</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 3</arm_group_label>
    <arm_group_label>Cereal extract concentration 1</arm_group_label>
    <arm_group_label>Cereal extract concentration 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cereal extract concentration 3</intervention_name>
    <description>Cereal extract will be given to see the effect on penetration and aspiration in patients with dysphagia problem</description>
    <arm_group_label>Thicken Up Clear concentration 1</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 2</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 3</arm_group_label>
    <arm_group_label>Cereal extract concentration 1</arm_group_label>
    <arm_group_label>Cereal extract concentration 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thicken up clear concentration 1</intervention_name>
    <description>Thicken up clear will be given to see the effect on penetration and aspiration in patients with dysphagia problem</description>
    <arm_group_label>Thicken Up Clear concentration 2</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 3</arm_group_label>
    <arm_group_label>Cereal extract concentration 1</arm_group_label>
    <arm_group_label>Cereal extract concentration 2</arm_group_label>
    <arm_group_label>Cereal extract concentration 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thicken up clear concentration 2</intervention_name>
    <description>Thicken up clear will be given to see the effect on penetration and aspiration in patients with dysphagia problem</description>
    <arm_group_label>Thicken Up Clear concentration 1</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 3</arm_group_label>
    <arm_group_label>Cereal extract concentration 1</arm_group_label>
    <arm_group_label>Cereal extract concentration 2</arm_group_label>
    <arm_group_label>Cereal extract concentration 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thicken up clear concentration 3</intervention_name>
    <description>Thicken up clear will be given to see the effect on penetration and aspiration in patients with dysphagia problem</description>
    <arm_group_label>Thicken Up Clear concentration 1</arm_group_label>
    <arm_group_label>Thicken Up Clear concentration 2</arm_group_label>
    <arm_group_label>Cereal extract concentration 1</arm_group_label>
    <arm_group_label>Cereal extract concentration 2</arm_group_label>
    <arm_group_label>Cereal extract concentration 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Mild dysphagia as defined by a score between 3 and 5 on the Dysphagia Outcome and
             Severity Scale

          2. Patients aged between 18 and 85 years

          3. Ischemic/hemorrhagic cerebral cause (stroke)

          4. Able to understand French (oral and written)

          5. Cognitive capacity enough to understand study procedures

          6. Having health insurance (which in France is &quot; social security&quot;)

          7. Having signed the consent form.

        Exclusion Criteria:

          1. Any swallowing trouble not resulting from the current stroke

          2. History of inhalation pneumopathy, i.e. any pulmonary inflammation linked to the path
             of a solid or liquid food in the respiratory system

          3. Any physician diagnosed psychiatric illness

          4. Patient with a digestive fistula

          5. Any physician diagnosed food allergy

          6. Any known allergy to barium or any compound of the contrast product

          7. Confirmed or suspected perforated and occlusive syndrome

          8. Pregnant or lactating women

          9. Major respiratory disease needing oxygen (chronic respiratory insufficiency)

         10. Subject who cannot be expected to comply with the study procedures, including
             consuming the test products.

         11. Currently participating or having participated in another clinical trial during the
             month preceding the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Eric VERIN, MD, PhD, HDR</last_name>
    <phone>+33 3 32 88 80 39</phone>
    <email>eric.verin@chu-rouen.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne-Marie Leroi, MD</last_name>
    <phone>+33-6-83-35-47-84</phone>
    <email>Anne-Marie.Leroi@chu-rouen.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Grand hopital de Charleroi</name>
      <address>
        <city>Charleroi</city>
        <zip>6000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Didier Bleeckx</last_name>
      <phone>071 10 80 22</phone>
      <email>Didier.Bleeckx@ghdc.be</email>
    </contact>
    <contact_backup>
      <last_name>Victoria Mariscal-Diaz</last_name>
      <email>v.mariscaldiaz@hotmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Charles Nicolle</name>
      <address>
        <city>Rouen</city>
        <zip>76031</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric VERIN, MD, PhD, HDR</last_name>
      <phone>+33 3 32 88 80 39</phone>
      <email>eric.verin@chu-rouen.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 24, 2016</lastchanged_date>
  <firstreceived_date>July 13, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Deglutition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
